|
Post publication peer
review acknowledgement
|
Congratulations to the
Department of Immunology researchers! Their article on chronic lymphocytic leukaemia (CLL) has been recommended by the
Faculty of 1000 as being of special significance in its field. The reviewer, Dr
Philippe Saas, writes, "these data may explain the vulnerability of CLL
patients to viral infections and provide therapeutic approaches (Flt3L
plus CpG ODN or anti-TNF plus anti-TGF-beta antibodies) to restore PDC
number and PDC capacity to produce type I IFN in peripheral lymphoid
tissues." References:
No comments:
Post a Comment
Thankyou for your comment. We moderate all messages and may take a little time to review your comment. Please email inquiries to ccs.comms@monash.edu.